Nichd Neonatal Research Network
Clinical trials sponsored by Nichd Neonatal Research Network, explained in plain language.
-
Could a simple drug combo save tiny preemies from deadly lung disease?
Disease control OngoingThis study tests whether adding budesonide (an anti-inflammatory drug) to standard surfactant therapy helps extremely preterm babies (born before 29 weeks or weighing under 2.2 pounds) avoid severe chronic lung disease or death. About 640 infants will receive either the combinati…
Phase: PHASE3 • Sponsor: NICHD Neonatal Research Network • Aim: Disease control
Last updated May 17, 2026 05:56 UTC
-
Premature baby heart trial: to treat or not to treat?
Disease control OngoingThis study looked at whether treating a common heart condition (patent ductus arteriosus) in premature babies is better than simply watching and waiting. About 482 infants born very early were included. The goal was to see which approach reduces the risk of death or serious lung …
Phase: PHASE3 • Sponsor: NICHD Neonatal Research Network • Aim: Disease control
Last updated May 17, 2026 05:51 UTC
-
Could cycling light therapy save more tiny preemies?
Disease control OngoingThis study compares cycled (on-and-off) phototherapy to continuous phototherapy in extremely premature infants (under 750 grams or 27 weeks gestation). The goal is to see if cycled treatment improves survival to discharge while still controlling bilirubin levels. About 1,700 babi…
Phase: NA • Sponsor: NICHD Neonatal Research Network • Aim: Disease control
Last updated May 08, 2026 12:04 UTC